CURRENT PERSPECTIVE OF THERAPIES TO GLIOMAS EXPRESSING HEPATOCYTE GROWTH FACTOR
Journal Title: Era's Journal of Medical Research - Year 2015, Vol 2, Issue 1
Abstract
This paper present about Glioblastma multiforme (GBM) is the most common malignant brain tumor of the central nervous system (CNS), the purpose is to investigate the scatter factor/hepatocyte growth factor (SF/HGF) and other current perspective therapies involved in the therapeutic interventions of CNS tumours which would provide excellent tumor control and regression, and may improve the prognosis and quality of life of patients with neurological tumours.
Authors and Affiliations
C. Rory Goodwin, Nancy Abu-Bonsrah, Christine Boone, Bachchu Lal
Keywords
Related Articles
- EP ID EP185733
- DOI -
- Views 107
- Downloads 0
BIORESORBABLE PLATES IN MANAGEMENT OF MANDIBULAR ANGLE FRACTURE
Rigid internal fixation of the jaw bones is a routine procedure for the management of facial fractures. Titanium plates and screws are routinely used for this purpose. The limitations of this system have led to the devel...
PAIN MANAGEMENT BY WHo STEP lADDER PATTERN PRoToCol IN CASES oF CERVICAl CANCER
To assess pain in cases of cancer cervix and to evaluate the response to pain management according to WHO step ladder pattern in cases of cancer cervix, total 209 carcinoma cervix diagnosed and admitted case were recruit...
LUNG CANCER STEM CELLS:AN UPDATE
Lung cancer is regarded as one of the most common cancers in the world with a worldwide occurrence of approximately 1.8 million cases and an estimated mortality of 1.6 million in 2012 alone.1 In the United States, there...
CANCER STEM CELL IN GLIOBLASTOMA MULTIFORME
Glioblastoma multiforme (GBM) is an aggressive tumor that typically exhibits treatment failure with high mortality rates, is associated with the presence of cancer stem cells (CSCs) within the tumor. CSCs possess the abi...
CORRELATION WITH VEGF LEVEL FOR CLINICAL IMPROVEMENT IN BUERGER'S DISEASE PATIENTS AFTER ILLIZAROV SURGERY
Buerger's disease also called thromboangiitis obliterans (TAO), is widely recognized as a specific disease characterized by onset of distal extremity ischemic symptoms at early age in absence of an underlying proximal em...